Freenome

Ovid eyes next chapter with CEO transition—Chutes & Ladders

Ovid's Levin set to become chairman as its next CEO stands ready. FDA’s oncology head takes top CDER post. Metagenomi shuffles CEO in reorg. Plus more.

Darren Incorvaia , Zoey Becker Nov 14, 2025 8:30am

J&J innovator vaults to Valo—Chutes & Ladders

Apr 11, 2025 8:30am

Roche leads Freenome's $254M fundraising for cancer blood tests

Feb 15, 2024 10:27am

Freenome picks up fellow cancer test maker Oncimmune for $16M

May 22, 2023 11:45am

JPM23: What's medtech's place at the conference? CEOs weigh in

Jan 12, 2023 9:45am

JPM23's Medtech Tidbits: Reporting from San Francisco

Jan 11, 2023 11:11am